LMOFX
Price
$48.16
Change
+$0.74 (+1.56%)
Updated
Oct 20 closing price
Net Assets
1.79B
VIEIX
Price
$160.73
Change
+$2.44 (+1.54%)
Updated
Oct 20 closing price
Net Assets
83.66B
Interact to see
Advertisement

LMOFX vs VIEIX

Header iconLMOFX vs VIEIX Comparison
Open Charts LMOFX vs VIEIXBanner chart's image
Patient Opportunity FI
Price$48.16
Change+$0.74 (+1.56%)
VolumeN/A
Net Assets1.79B
Vanguard Extended Market Index Instl
Price$160.73
Change+$2.44 (+1.54%)
VolumeN/A
Net Assets83.66B
LMOFX vs VIEIX Comparison Chart in %
View a ticker or compare two or three
VS
LMOFX vs. VIEIX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMOFX is a Buy and VIEIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIEIX has more cash in the bank: 83.7B vs. LMOFX (1.79B). VIEIX pays higher dividends than LMOFX: VIEIX (1.10) vs LMOFX (0.00). LMOFX was incepted earlier than VIEIX: LMOFX (22 years) vs VIEIX (28 years). LMOFX (1.83) is less costly to investors than VIEIX (0.05). LMOFX is a more actively managed with annual turnover of: 31.00 vs. VIEIX (11.00). LMOFX has a lower initial minimum investment than VIEIX: LMOFX (0) vs VIEIX (5000000). LMOFX annual gain was more profitable for investors over the last year : 26.64 vs. VIEIX (13.15). VIEIX return over 5 years is better than : 57.49 vs. LMOFX (51.49).
LMOFXVIEIXLMOFX / VIEIX
Total Expense Ratio1.820.053,640%
Annual Report Gross Expense Ratio1.830.053,660%
Fund Existence22 years28 years-
Gain YTD22.17111.803188%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.79B83.7B2%
Annual Yield % from dividends0.001.10-
Returns for 1 year26.6413.15203%
Returns for 3 years78.9762.70126%
Returns for 5 years51.4957.4990%
Returns for 10 years131.98155.6485%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRZBF35.401.25
+3.66%
Commerzbank AG
MDXXF0.08N/A
N/A
PharmAla Biotech Holdings Inc.
LNZNF29.25N/A
N/A
Lenzing AG
GEDSF22.29N/A
N/A
Gedeon Richter Ltd
ANSNF0.07N/A
N/A
Anson Resources